SeqFeatR for the Discovery of Feature-Sequence Associations

由 Budeus, Bettina, Timm, Jörg, Hoffmann, Daniel
發表在 PLoS One (2016)

Genotypic resistance testing of HCV – is there a clinical need?

由 Walker, Andreas, Kaiser, Rolf, Bartenschlager, Ralf, Timm, Jörg
出版 2016-08-01

Genotypic resistance testing of HCV – is there a clinical need?

由 Walker, Andreas, Kaiser, Rolf, Bartenschlager, Ralf, Timm, Jörg
發表在 GMS Infect Dis (2016)

Multicentric Castleman’s disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018

由 Gliga, Smaranda, Orth, Hans Martin, Lübke, Nadine, Timm, Jörg, Luedde, Tom, Jensen, Björn-Erik Ole
發表在 Infection (2021)

Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials

由 Lübke, Nadine, Senff, Tina, Scherger, Sara, Hauka, Sandra, Andrée, Marcel, Adams, Ortwin, Timm, Jörg, Walker, Andreas
發表在 J Clin Virol (2020)

Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations

由 Duwe, Susanne C., Schmidt, Barbara, Gärtner, Barbara C., Timm, Jörg, Adams, Ortwin, Fickenscher, Helmut, Schmidtke, Michaela
發表在 GMS Infect Dis (2021)

Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+ T Cells Is Linked to Antigen Recognition and T Cell Differentiation

由 Bengsch, Bertram, Seigel, Bianca, Ruhl, Marianne, Timm, Jörg, Kuntz, Martin, Blum, Hubert E., Pircher, Hanspeter, Thimme, Robert
出版 2010

Detection of a genetic footprint of the sofosbuvir resistance-associated substitution S282T after HCV treatment failure

由 Walker, Andreas, Filke, Sandra, Lübke, Nadine, Obermeier, Martin, Kaiser, Rolf, Häussinger, Dieter, Timm, Jörg, Bock, Hans H.
發表在 Virol J (2017)

Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV)

由 Kindgen-Milles, Detlef, Brandenburger, Timo, Braun, Julian F. W., Cleff, Corvin, Moussazadeh, Kian, Mrosewski, Ingo, Timm, Jörg, Wetzchewald, Dietmar
發表在 PLoS One (2021)

Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant

由 Herzer, Kerstin, Papadopoulos-Köhn, Angela, Achterfeld, Anne, Canbay, Ali, Piras-Straub, Katja, Paul, Andreas, Walker, Andreas, Timm, Jörg, Gerken, Guido
發表在 World J Hepatol (2015)

HCMV Infection in a Mesenchymal Stem Cell Niche: Differential Impact on the Development of NK Cells versus ILC3

由 Ising, Ricarda, Weinhold, Sandra, Bennstein, Sabrina Bianca, Zimmermann, Albert, Degistirici, Özer, Kögler, Gesine, Meisel, Roland, Hengel, Hartmut, Timm, Jörg, Uhrberg, Markus
發表在 J Clin Med (2019)

Effective Activation of Human Antigen-Presenting Cells and Cytotoxic CD8(+) T Cells by a Calcium Phosphate-Based Nanoparticle Vaccine Delivery System

由 Scheffel, Florian, Knuschke, Torben, Otto, Lucas, Kollenda, Sebastian, Sokolova, Viktoriya, Cosmovici, Christine, Buer, Jan, Timm, Jörg, Epple, Matthias, Westendorf, Astrid M.
發表在 Vaccines (Basel) (2020)

SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission

由 Corman, Victor M., Rabenau, Holger F., Adams, Ortwin, Oberle, Doris, Funk, Markus B., Keller‐Stanislawski, Brigitte, Timm, Jörg, Drosten, Christian, Ciesek, Sandra
發表在 Transfusion (2020)

Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C

由 Gieseler, Robert K., Marquitan, Guido, Schlattjan, Martin, Sowa, Jan-Peter, Bechmann, Lars P., Timm, Jörg, Roggendorf, Michael, Gerken, Guido, Friedman, Scott L., Canbay, Ali
出版 2010

Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome

由 Nowak, Knut Michael, Witzke, Oliver, Sotiropoulos, Georgios C., Benkö, Tamas, Fiedler, Melanie, Timm, Jörg, Kribben, Andreas, Wilde, Benjamin, Saner, Fuat, Paul, Andreas, Treckmann, Jürgen
發表在 Kidney Int Rep (2016)

Differential escape of HCV from CD8(+) T cell selection pressure between China and Germany depends on the presenting HLA class I molecule

由 Xia, Youchen, Pan, Wen, Ke, Xiaoyu, Skibbe, Kathrin, Walker, Andreas, Hoffmann, Daniel, Lu, Yinping, Yang, Xuecheng, Feng, Xuemei, Tong, Qiaoxia, Timm, Jörg, Yang, Dongliang
發表在 J Viral Hepat (2018)

Impact of Sequence Variation in a Dominant HLA-A*02-Restricted Epitope in Hepatitis C Virus on Priming and Cross-Reactivity of CD8(+) T Cells

由 Ziegler, Susanne, Skibbe, Kathrin, Walker, Andreas, Ke, Xiaoyu, Heinemann, Falko M., Heinold, Andreas, Mok, Juk Yee, van Esch, Wim J. E., Yang, Dongliang, Wölfl, Matthias, Timm, Jörg
出版 2014

High Concentration of Low-Density Lipoprotein Results in Disturbances in Mitochondrial Transcription and Functionality in Endothelial Cells

由 Gonnissen, Stefanie, Ptok, Johannes, Goy, Christine, Jander, Kirsten, Jakobs, Philipp, Eckermann, Olaf, Kaisers, Wolfgang, von Ameln, Florian, Timm, Jörg, Ale-Agha, Niloofar, Haendeler, Judith, Schaal, Heiner, Altschmied, Joachim
發表在 Oxid Med Cell Longev (2019)

Escape from a Dominant HLA-B*15-Restricted CD8(+) T Cell Response against Hepatitis C Virus Requires Compensatory Mutations outside the Epitope

由 Ruhl, Marianne, Chhatwal, Patrick, Strathmann, Heiko, Kuntzen, Thomas, Bankwitz, Dorothea, Skibbe, Kathrin, Walker, Andreas, Heinemann, Falko M., Horn, Peter A., Allen, Todd M., Hoffmann, Daniel, Pietschmann, Thomas, Timm, Jörg
出版 2012

Hepatitis C Virus Hypervariable Region 1 Variants Presented on Hepatitis B Virus Capsid-Like Particles Induce Cross-Neutralizing Antibodies

由 Lange, Milena, Fiedler, Melanie, Bankwitz, Dorothea, Osburn, William, Viazov, Sergei, Brovko, Olena, Zekri, Abdel-Rahman, Khudyakov, Yury, Nassal, Michael, Pumpens, Paul, Pietschmann, Thomas, Timm, Jörg, Roggendorf, Michael, Walker, Andreas
出版 2014